Alembic releases generic Zomig
Zolmitriptan is a serotonin receptor agonist indicated for the acute treatment of migraine with or without aura in adults.
Alembic is introducing Zolmitriptan Tablets, 2.5 mg and 5 mg, which are the generic of IPR Pharmaceuticals’ Zomig.
Zolmitriptan is a serotonin (5-HT) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults.
[Read more: Alembic intros generic Perforomist]
Alembic will offer Zolmitriptan Tablets in strengths of 2.5mg in a 6-ct. blister pack, and 5 mg in a 3-ct. blister pack.